The next Editor-in-Chief of The Journal of Pathology, Prof J Louise Jones

09 August 2022 (Last updated: 10 Aug 2022 18:02)

Appointment of the next Editor-in-Chief of The Journal of Pathology: 

The Pathological Society is delighted to announce that Professor Louise Jones of the Barts Cancer Institute, Queen Mary University London, has been appointed to be the next Editor-in-Chief of The Journal of Pathology.

Louise is a very highly regarded academic histopathologist with an active laboratory-based research programme alongside clinical diagnostic work, who is passionate about the application of basic science to the understanding of human disease mechanisms and behaviour, including the integration of basic science with clinical research. Louise takes over the position of Editor-in-Chief of the Journal of Pathology from Professor C. Simon Herrington of the University of Edinburgh, although Simon continues as the Editor-in-Chief of the Journal of Pathology: Clinical Research. 

The Society would like to take this opportunity to give considerable thanks to Simon for his two stints as Editor-in-Chief of the Journal of Pathology, which have both been highly successful involving increases in the journal's impact factor and general standing in the pathology literature.

Yours faithfully,

M Arends, G Murray, S Coupland

President, Treasurer, and General Secretary of the Society

 

Short biography: Prof J Louise Jones

Professor of Breast Pathology, Barts Health NHS Trust and head of Breast Pathology Research Group in Centre for Tumour Biology, Barts Cancer Institute.

Trained at University of Leicester and did a PhD in Control of Breast Cancer Cell Invasion. Main research focus is on the role of the microenvironment in mediating progression of DCIS to invasion, and the biology of high Mammographic Density.

Head of the National Breast Cancer Now Biobank including the Breast Cell bank which isolated primary cell populations for in-vitro functional studies. Lead for Molecular Pathology with Genomics England. Cellular Pathology Lead for North Thames GLH and Chair for Cell Path Genomics Focus Group, the RCPath Genomic Medicine and Reproductive Science Specialist Advisory Committee.

 

View other News